{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:21:32Z","timestamp":1772166092342,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Intervertebral disc degeneration, one of the major causes of low-back pain, results from altered biosynthesis\/turnover of extracellular matrix in the disc. Previously, we reported that the analgesic drug Neurotropin\u00ae (NTP) had an anabolic effect on glycosaminoglycan synthesis in cultured nucleus pulposus (NP) cells via the stimulation of chondroitin sulfate\n                      <jats:italic>N<\/jats:italic>\n                      -acetylgalactosaminyltransferase 1. However, its effect on the aggrecan core protein was not significantly detected, because of the data variance. A microarray analysis suggested that the effect of NTP on aggrecan was correlated with\n                      <jats:italic>N<\/jats:italic>\n                      -acetyltransferase 2 (NAT2), a drug-metabolizing enzyme. Specific\n                      <jats:italic>NAT2<\/jats:italic>\n                      alleles are known to correlate with rapid, intermediate, and slow acetylation activities and side effects of various drugs. We investigated the association between the efficacy of NTP on aggrecan expression and the\n                      <jats:italic>NAT2<\/jats:italic>\n                      genotype in cell donors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      NP cells were isolated from intervertebral disc tissues donated by 31 Japanese patients (28\u201368\u00a0years) who underwent discectomy. NTP was added to the primary cell cultures and its effect on the aggrecan mRNA was analyzed using real-time quantitative PCR. To assess acetylator status, genotyping was performed based on the inferred\n                      <jats:italic>NAT2<\/jats:italic>\n                      haplotypes of five common single-nucleotide polymorphisms using allele-specific PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The phenotype frequencies of\n                      <jats:italic>NAT2<\/jats:italic>\n                      in the patients were 0%, 42.0%, and 58.0% for slow, intermediate, and rapid acetylators, respectively. The proportions of responders to NTP treatment (aggrecan upregulation,\u2009\u2265\u20091.1-fold) in the intermediate and rapid acetylators were 76.9% and 38.9%, respectively. The odds ratio of the comparison of the intermediate acetylator status between responders and nonresponders was 5.2 (95% CI 1.06\u201326.0, P\u2009=\u20090.036), and regarding the 19 male patients, this was 14.0 (95% CI 1.54\u2013127.2,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012). In the 12 females, the effect was not correlated with\n                      <jats:italic>NAT2<\/jats:italic>\n                      phenotype but seemed to become weaker along with aging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      An intermediate acetylator status significantly favored the efficacy of NTP treatment to enhance aggrecan production in NP cells. In males, this tendency was detected with higher significance. This study provides suggestive data of the association between\n                      <jats:italic>NAT2<\/jats:italic>\n                      variants and the efficacy of NTP treatment. Given the small sample size, results should be further confirmed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-021-00926-x","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:03:13Z","timestamp":1615442593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of NAT2 genetic polymorphism with the efficacy of Neurotropin\u00ae for the enhancement of aggrecan gene expression in nucleus pulposus cells: a pilot study"],"prefix":"10.1186","volume":"14","author":[{"given":"Tomoko","family":"Nakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Horikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Naiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"issue":"3","key":"926_CR1","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1002\/jsp2.1026","volume":"1","author":"BV Fearing","year":"2018","unstructured":"Fearing BV, Hernandez PA, Setton LA, Chahine NO. Mechanotransduction and cell biomechanics of the intervertebral disc. JOR Spine. 2018;1(3):e1026.","journal-title":"JOR Spine"},{"issue":"10","key":"926_CR2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/00007632-199705150-00006","volume":"22","author":"T Handa","year":"1997","unstructured":"Handa T, Ishihara H, Ohshima H, Osada R, Tsuji H, Obata K. Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine. 1997;22(10):1085\u201391.","journal-title":"Spine"},{"issue":"4","key":"926_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0736-0266(03)00027-5","volume":"21","author":"MGV Kasra","year":"2003","unstructured":"Kasra MGV, Martin J, Wang ST, Choi W, Buckwalter J. Effect of dynamic hydrostatic pressure on rabbit intervertebral disc cells. J Orthop Res. 2003;21(4):597\u2013603.","journal-title":"J Orthop Res"},{"issue":"Suppl 3","key":"926_CR4","doi-asserted-by":"publisher","first-page":"S372","DOI":"10.1007\/s00586-006-0112-1","volume":"15","author":"C Neidlinger-Wilke","year":"2006","unstructured":"Neidlinger-Wilke C, Wurtz K, Urban JP, Borm W, Arand M, Ignatius A, Wilke HJ, Claes LE. Regulation of gene expression in intervertebral disc cells by low and high hydrostatic pressure. Eur Spine J. 2006;15(Suppl 3):S372-378.","journal-title":"Eur Spine J"},{"issue":"6","key":"926_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.spinee.2013.07.490","volume":"15","author":"S Ohtori","year":"2015","unstructured":"Ohtori S, Inoue G, Miyagi M, Takahashi K. Pathomechanisms of discogenic low back pain in humans and animal models. Spine J. 2015;15(6):1347\u201355.","journal-title":"Spine J"},{"issue":"10","key":"926_CR6","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1016\/j.bbagen.2014.07.013","volume":"1840","author":"S Sivan","year":"2014","unstructured":"Sivan S, Wachtel E, Roughley P. Structure, function, aging and turnover of aggrecan in the intervertebral disc. Biochim Biophys Acta. 2014;1840(10):3181\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"926_CR7","doi-asserted-by":"publisher","first-page":"e0202640","DOI":"10.1371\/journal.pone.0202640","volume":"13","author":"D Sakai","year":"2018","unstructured":"Sakai D, Nakai T, Hiraishi S, Nakamura Y, Ando K, Naiki M, Watanabe M. Upregulation of glycosaminoglycan synthesis by Neurotropin in nucleus pulposus cells via stimulation of chondroitin sulfate N-acetylgalactosaminyltransferase 1: a new approach to attenuation of intervertebral disc degeneration. PLoS ONE. 2018;13(8):e0202640.","journal-title":"PLoS ONE"},{"issue":"3","key":"926_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00540-006-0399-4","volume":"20","author":"T Nishiyama","year":"2006","unstructured":"Nishiyama T, Matsukawa T, Yamashita K. Comparison between neurotropin and mepivacaine for stellate ganglion injection. J Anesth. 2006;20(3):240\u20132.","journal-title":"J Anesth"},{"issue":"6","key":"926_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10194-011-0382-9","volume":"12","author":"Y Yamazaki","year":"2011","unstructured":"Yamazaki Y, Kobatake K. Successful treatment of nummular headache with Neurotropin(R). J Headache Pain. 2011;12(6):661\u20132.","journal-title":"J Headache Pain"},{"key":"926_CR10","first-page":"837","volume":"21","author":"K Ono","year":"1987","unstructured":"Ono K, Ochi T, Yonenobu S, Ogawa N. Usefulness of neurotropin tablet for low back pain and shoulder-arm-neck syndrome\u2014a ketoprofen and placebo controlled double-blind trial. Clin Rep. 1987;21:837\u201373 ((in Japanese)).","journal-title":"Clin Rep"},{"issue":"4","key":"926_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1526-4637.2007.00279.x","volume":"9","author":"K Toda","year":"2008","unstructured":"Toda K, Tobimatsu Y. Efficacy of neurotropin in fibromyalgia: a case report. Pain Med. 2008;9(4):460\u20133.","journal-title":"Pain Med"},{"issue":"2","key":"926_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/ijms19020516","volume":"19","author":"H Matsuoka","year":"2018","unstructured":"Matsuoka H, Tanaka H, Sayanagi J, Iwahashi T, Suzuki K, Nishimoto S, Okada K, Murase T, Yoshikawa H. Neurotropin((R)) accelerates the differentiation of schwann cells and remyelination in a rat lysophosphatidylcholine-induced demyelination model. Int J Mol Sci. 2018;19(2):516.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"926_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3171\/SPI.2008.9.11.411","volume":"9","author":"T Yoshida","year":"2008","unstructured":"Yoshida T, Park JS, Yokosuka K, Jimbo K, Yamada K, Sato K, Nagata K. Effect of a nonprotein bioactive agent on the reduction of cyclooxygenase-2 and tumor necrosis factor-alpha in human intervertebral disc cells in vitro. J Neurosurg Spine. 2008;9(5):411\u20138.","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"926_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s100380170065","volume":"46","author":"A Sekine","year":"2001","unstructured":"Sekine A, Saito S, Iida A, Mitsunobu Y, Higuchi S, Harigae S, Nakamura Y. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J Hum Genet. 2001;46(6):314\u20139.","journal-title":"J Hum Genet"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2156-9-21","volume":"9","author":"A Sabbagh","year":"2008","unstructured":"Sabbagh A, Langaney A, Darlu P, G\u00e9rard N, Krishnamoorthy R, Poloni ES. Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genet. 2008;9:21.","journal-title":"BMC Genet"},{"issue":"10","key":"926_CR16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5588\/ijtld.15.0310","volume":"20","author":"S Wattanapokayakit","year":"2016","unstructured":"Wattanapokayakit S, Mushiroda T, Yanai H, Wichukchinda N, Chuchottawon C, Nedsuwan S, Rojanawiwat A, Denjanta S, Kantima T, Wongyai J, et al. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients. Int J Tuberc Lung Dis. 2016;20(10):1364\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"926_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/hmg\/3.5.729","volume":"3","author":"DW Hein","year":"1994","unstructured":"Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet. 1994;3(5):729\u201334.","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"926_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0027-5107(97)00026-2","volume":"376","author":"DM Grant","year":"1997","unstructured":"Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL, Grewal R. Human acetyltransferase polymorphisms. Mutat Res. 1997;376(1\u20132):61\u201370.","journal-title":"Mutat Res"},{"issue":"3","key":"926_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00008571-199806000-00009","volume":"8","author":"HJ Lin","year":"1998","unstructured":"Lin HJ, Probst-Hensch NM, Hughes NC, Sakamoto GT, Louie AD, Kau IH, Lin BK, Lee DB, Lin J, Frankl HD, et al. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics. 1998;8(3):269\u201381.","journal-title":"Pharmacogenetics"},{"issue":"49","key":"926_CR20","doi-asserted-by":"publisher","first-page":"34519","DOI":"10.1074\/jbc.274.49.34519","volume":"274","author":"MA Leff","year":"1999","unstructured":"Leff MA, Fretland AJ, Doll MA, Hein DW. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype. J Biol Chem. 1999;274(49):34519\u201322.","journal-title":"J Biol Chem"},{"issue":"4","key":"926_CR21","doi-asserted-by":"publisher","first-page":"e18507","DOI":"10.1371\/journal.pone.0018507","volume":"6","author":"A Sabbagh","year":"2011","unstructured":"Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS ONE. 2011;6(4):e18507.","journal-title":"PLoS ONE"},{"issue":"6","key":"926_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/138920008784892038","volume":"9","author":"JM Ladero","year":"2008","unstructured":"Ladero JM. Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs. Curr Drug Metab. 2008;9(6):532\u20137.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"926_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/138920008784892083","volume":"9","author":"JA Ag\u00fandez","year":"2008","unstructured":"Ag\u00fandez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab. 2008;9(6):520\u201331.","journal-title":"Curr Drug Metab"},{"issue":"1","key":"926_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2353\/jmoldx.2009.080039","volume":"11","author":"E Gineikiene","year":"2009","unstructured":"Gineikiene E, Stoskus M, Griskevicius L. Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring. J Mol Diagn JMD. 2009;11(1):66\u201374.","journal-title":"J Mol Diagn JMD"},{"issue":"31","key":"926_CR25","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.3748\/wjg.v11.i31.4833","volume":"11","author":"H Machida","year":"2005","unstructured":"Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, et al. Crohn\u2019s disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol. 2005;11(31):4833\u20137.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"926_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.spinee.2020.04.006","volume":"20","author":"DS Kreiner","year":"2020","unstructured":"Kreiner DS, Matz P, Bono CM, Cho CH, Easa JE, Ghiselli G, Ghogawala Z, Reitman CA, Resnick DK, Watters WC 3rd, et al. Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain. Spine J. 2020;20(7):998\u20131024.","journal-title":"Spine J"},{"issue":"1","key":"926_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pmrj.2010.09.006","volume":"3","author":"MJ Depalma","year":"2011","unstructured":"Depalma MJ, Ketchum JM, Trussell BS, Saullo TR, Slipman CW. Does the location of low back pain predict its source? PM&R J Inj Funct Rehab. 2011;3(1):33\u20139.","journal-title":"PM&R J Inj Funct Rehab"},{"issue":"11","key":"926_CR28","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/0091270006292249","volume":"46","author":"MB O'Connell","year":"2006","unstructured":"O\u2019Connell MB, Frye RF, Matzke GR, St Peter JV, Willhite LA, Welch MR, Kowal P, LaValleur J. Effect of conjugated equine estrogens on oxidative metabolism in middle-aged and elderly postmenopausal women. J Clin Pharmacol. 2006;46(11):1299\u2013307.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"926_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1203\/00006450-199903000-00019","volume":"45","author":"E Zieli\u0144ska","year":"1999","unstructured":"Zieli\u0144ska E, Bodalski J, Niewiarowski W, Bolanowski W, Matusiak I. Comparison of acetylation phenotype with genotype coding for N-acetyltransferase (NAT2) in children. Pediatr Res. 1999;45(3):403\u20138.","journal-title":"Pediatr Res"},{"issue":"2","key":"926_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/toxsci\/kfg086","volume":"73","author":"CA McQueen","year":"2003","unstructured":"McQueen CA, Chau B. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity. Toxicol Sci. 2003;73(2):279\u201386.","journal-title":"Toxicol Sci"},{"key":"926_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bcp.2018.08.034","volume":"156","author":"RA Salazar-Gonz\u00e1lez","year":"2018","unstructured":"Salazar-Gonz\u00e1lez RA, Turij\u00e1n-Espinoza E, Hein DW, Mil\u00e1n-Segovia RC, Uresti-Rivera EE, Portales-P\u00e9rez DP. Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1. Biochem Pharmacol. 2018;156:340\u20137.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"926_CR32","doi-asserted-by":"publisher","first-page":"e0144955","DOI":"10.1371\/journal.pone.0144955","volume":"10","author":"H Wang","year":"2015","unstructured":"Wang H, Iwasaki M, Haiman CA, Kono S, Wilkens LR, Keku TO, Berndt SI, Tsugane S, Le Marchand L. Interaction between red meat intake and NAT2 genotype in increasing the risk of colorectal cancer in Japanese and African Americans. PLoS ONE. 2015;10(12):e0144955.","journal-title":"PLoS ONE"},{"issue":"9","key":"926_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1021\/tx7001614","volume":"20","author":"LVVA Liu","year":"2007","unstructured":"Liu LVVA, Zhang N, Walters KJ, Wagner CR, Hanna PE. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Chem Res Toxicol. 2007;20(9):1300\u20138.","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"926_CR34","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/01.mlg.0000183694.10583.12","volume":"115","author":"M Unal","year":"2005","unstructured":"Unal M, Tamer L, Do\u011fruer ZN, Yildirim H, Vayiso\u011flu Y, Camdeviren H. N-acetyltransferase 2 gene polymorphism and presbycusis. Laryngoscope. 2005;115(12):2238\u201341.","journal-title":"Laryngoscope"},{"key":"926_CR35","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/ncomms2226","volume":"3","author":"D Sakai","year":"2012","unstructured":"Sakai D, Nakamura Y, Nakai T, Mishima T, Kato S, Grad S, Alini M, Risbud MV, Chan D, Cheah KS, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun. 2012;3:1264.","journal-title":"Nat Commun"},{"issue":"5","key":"926_CR36","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ajhg.2008.03.013","volume":"82","author":"Y Hirose","year":"2008","unstructured":"Hirose Y, Chiba K, Karasugi T, Nakajima M, Kawaguchi Y, Mikami Y, Furuichi T, Mio F, Miyake A, Miyamoto T, et al. A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation. Am J Hum Genet. 2008;82(5):1122\u20139.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"926_CR37","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1359\/jbmr.090314","volume":"24","author":"T Karasugi","year":"2009","unstructured":"Karasugi T, Semba K, Hirose Y, Kelempisioti A, Nakajima M, Miyake A, Furuichi T, Kawaguchi Y, Mikami Y, Chiba K, et al. Association of the tag SNPs in the human SKT gene (KIAA1217) with lumbar disc herniation. J Bone Miner Res. 2009;24(9):1537\u201343.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"926_CR38","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.18632\/aging.103150","volume":"12","author":"J Chen","year":"2020","unstructured":"Chen J, Zhao X, Cui L, He G, Wang X, Wang F, Duan S, He L, Li Q, Yu X, et al. Genetic regulatory subnetworks and key regulating genes in rat hippocampus perturbed by prenatal malnutrition: implications for major brain disorders. Aging. 2020;12(9):8434\u201358.","journal-title":"Aging"},{"issue":"18","key":"926_CR39","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.18632\/aging.102275","volume":"11","author":"H Li","year":"2019","unstructured":"Li H, Wang X, Lu X, Zhu H, Li S, Duan S, Zhao X, Zhang F, Alterovitz G, Wang F, et al. Co-expression network analysis identified hub genes critical to triglyceride and free fatty acid metabolism as key regulators of age-related vascular dysfunction in mice. Aging. 2019;11(18):7620\u201338.","journal-title":"Aging"},{"issue":"1","key":"926_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41398-020-00902-6","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu Y, Cao H, Baranova A, Huang H, Li S, Cai L, Rao S, Dai M, Xie M, Dou Y, et al. Multi-trait analysis for genome-wide association study of five psychiatric disorders. Transl Psych. 2020;10(1):209.","journal-title":"Transl Psych"},{"issue":"10","key":"926_CR41","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1210\/jc.2019-00495","volume":"104","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang K, Lo K, Zhong Y, Yang A, Fang X, Akezhuoli H, Song Z, Chen L, An P, et al. Sex-specific association of circulating ferritin level and risk of type 2 diabetes: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2019;104(10):4539\u201351.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-00926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-021-00926-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-00926-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T06:12:43Z","timestamp":1615443163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-021-00926-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/s12920-021-00926-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-131581\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Tokai University School of Medicine (study code: 18I-25), and was conducted in accordance with approved protocols. Informed consent forms with written provision were completed by all patients before the donation of samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"<i>NAT2<\/i> genotyping data and intervertebral disc samples were obtained with written informed consent. All data are anonymized and no information is traceable to any individual patient. All authors have read the manuscript and agreed to its content. This work is original and is not currently under consideration by another journal. A funder provided research grant for this study, Nippon Zoki Pharmaceutical Company Ltd. consented to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors, T.N., D.S., and M.W. received a research grant from Nippon Zoki Pharmaceutical Company Ltd. T.N. received a salary afforded by this grant. M.N. is employed by the company. Other authors, Y.N., N.H., and E.M. have no competing interests. The funder will not in any way gain or lose financially from the publication of\u00a0this manuscript, either now or in the future. The authors do not hold any stocks or shares in an organisation that may in any way gain or lose financially from the publication of this manuscript, either now or in the future. The authors do not hold or currently applying for any patents relating to the content of the manuscript.\u00a0The authors have not received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript. The authors do not have any other financial competing interests in relation to this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}